Farmacross India Private Limited, a active private limited company, was established on 11 January 2001 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24239MH2001PTC130422. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.50 Cr and a paid-up capital of ₹1.01 Cr.
It upholds a compliant status. Employing 85 professional, Its leadership includes Yaaresh Gilan Ferzandi (Director), Parvin Plumarz Ferzandi (Director), Rehan Gilan Ferzandi (Additional Director). Past directors included Francis Pinto, Yaaresh Gilan Ferzandi, Plumarz Kaikhushru Ferzandi. It holds ₹2.59 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 75/77, 1St Floor, Above Union Bank Of India, Sant Savata Marg, Byculla East,, Mumbai, Maharashtra, 400010.
U24239MH2001PTC130422
130422
11 January 2001
₹1.50 Cr
₹1.01 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Farmacross India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Yaaresh Gilan Ferzandi | Director | 07 Jul 2020 | Current |
| Parvin Plumarz Ferzandi | Director | 03 Apr 2020 | Current |
| Rehan Gilan Ferzandi | Additional Director | 03 Jan 2025 | Current |
| Khushnuma Gilan Ferzandi | Director | 01 Nov 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 16 Apr 2009 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2020 | Past |
| Pramod Abcsdd | Director | 03 Jun 2020 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2020 | Past |
| Pramod Abcsdd | Director | 01 Nov 2012 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Farmacross India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.87% increase. The company also saw a substantial improvement in profitability, with a 33.3% increase in profit. The company's net worth Soared by an impressive increase of 34.94%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Farmacross India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,588,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Oct 2022 | Hdfc Bank Limited | ₹2.59 M | Open |
Explore comprehensive loan charge details -
Farmacross India has a workforce of 85 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Farmacross India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Farmacross India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Farmacross India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
Farmacross India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
Rehan Gilan Ferzandi was appointed as a Additional Director was appointed as a Additional Director on 03 Jan 2025 & has been associated with this company since 10 months 28 days . was recorded as a recent event.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.26 Cr with Charge ID 100619601 was registered on 03 Oct 2022. was documented.
Progress on Yaaresh Gilan Ferzandi was appointed as a Director was appointed as a Director on 07 Jul 2020 & has been associated with this company since 5 years 4 months . was documented.
The activity Parvin Plumarz Ferzandi was appointed as a Director was appointed as a Director on 03 Apr 2020 & has been associated with this company since 5 years 7 months . was completed.
The CIN of Farmacross India Private Limited is U24239MH2001PTC130422.
Farmacross India Private Limited is headquartered at 75/77, 1St Floor, Above Union Bank Of India, Sant Savata Marg, Byculla East,, Mumbai, Maharashtra, 400010.
Farmacross India Private Limited was incorporated on 11 January 2001.
The current directors of Farmacross India Private Limited are
The primary industry of Farmacross India Private Limited is Trade.
Farmacross India Private Limited is unlisted.
The authorized capital of Farmacross India Private Limited is ₹1.50 Cr, and the paid-up capital is ₹1.01 Cr.
The compliance status of Farmacross India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX